| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/10/2008 | EP1967191A1 Controlled/modified release oral methylphenidate formulations |
| 09/10/2008 | EP1966215A1 Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 09/10/2008 | EP1966209A1 [ 1h- indol- 5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders. |
| 09/10/2008 | EP1966208A1 (1-aza-bicycloý3.3.1¨n0n-4-yl)-ý5-(ih-indol-5-yl)-heteroaryl¨-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders |
| 09/10/2008 | EP1966200A1 Heterocyclic janus kinase 3 inhibitors |
| 09/10/2008 | EP1966191A1 Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists |
| 09/10/2008 | EP1966185A2 2-AMINO-5-PIPERIDINYLIMIDAZOLONE COMPOUNDS AND USE THEREOF FOR ß-SECRETASE MODULATION |
| 09/10/2008 | EP1966160A1 SUBSTITUTED 2-AMINOPYRIMIDINE-4-ONES, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF Aß-RELATED PATHOLOGIES |
| 09/10/2008 | EP1966158A1 Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis |
| 09/10/2008 | EP1966146A1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |
| 09/10/2008 | EP1966142A2 New phenanthridine derivatives as bradykinin antagonists |
| 09/10/2008 | EP1966138A2 Substituted tricyclic piperidone derivatives |
| 09/10/2008 | EP1965794A2 Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists |
| 09/10/2008 | EP1965788A1 Pharmaceutical composition containing omega-3 fatty acids and a silica |
| 09/10/2008 | EP1965780A2 Substituted phenol derivatives as analgesics |
| 09/10/2008 | EP1868626B1 Improved method for preparing ginkgo extracts having a reduced content of polycyclic aromatic hydrocarbons |
| 09/10/2008 | EP1846011A4 Composition comprising the extract of crude drug complex having neuroprotective activity for preventing and treating stroke and neurodegenerative diseases |
| 09/10/2008 | EP1735308B1 Fused ring azadecalin glucocorticoid receptor modulators |
| 09/10/2008 | EP1486501B1 Aminomethyl-substituted thiazolobenzimidazole derivative |
| 09/10/2008 | EP1474440B1 Coniosulphides and their derivatives, method for their production and use as medicaments |
| 09/10/2008 | EP1438053B1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 09/10/2008 | EP1427708B1 Amino-phthalazinone derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 09/10/2008 | EP1368302B1 Novel amino dicarboxylic acid derivatives |
| 09/10/2008 | EP1349861B1 THIENO(3,2-d)PYRIMIDINES AND FURANO(3,2-d)PYRIMIDINES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 09/10/2008 | EP1261337B1 Topoisomerase inhibitors for treatment of surgical adhesions |
| 09/10/2008 | EP1200124B1 Erythropoietin-immunoglobulin fusion proteins |
| 09/10/2008 | EP1159006B1 Water-soluble compositions of bioactive lipophilic compounds |
| 09/10/2008 | EP1131356B1 Monoclonal anti alpha-D (ITGAD) antibody for use in the treatment of CNS injuries caused by trauma |
| 09/10/2008 | CN101263139A Isoxazolo derivatives as GABA A alpha5 inverse agonists |
| 09/10/2008 | CN101263138A Salicylate and gentisate salts of a piperazine compound |
| 09/10/2008 | CN101263136A Benzimidazole derivatives as 5-HT6, 5-HT24 |
| 09/10/2008 | CN101263122A 1,2-diarylimidazoles for use as CB1 modulators |
| 09/10/2008 | CN101263120A 4,5-dihydro-1h-pyrazole derivatives, their preparation and use as medicaments |
| 09/10/2008 | CN101263112A Histamine H3 receptor agents, preparation and therapeutic uses |
| 09/10/2008 | CN101262869A Multiple sclerosis therapy and diagnosis |
| 09/10/2008 | CN101262868A Sustained-release formulation comprising a glucuronate salt of a piperazine compound and uses thereof |
| 09/10/2008 | CN101262857A 3-(2-dimethylaminomethyl cyclohexyl) phenol retard formulation |
| 09/10/2008 | CN101260092A Method for preparing cinepazide maleate |
| 09/10/2008 | CN101260075A Aralkylpiperidine derivative and application thereof in preparing analgesic and sedative medicament |
| 09/10/2008 | CN101260063A Gamma-aminobutyric acid derivative and its preparing process |
| 09/10/2008 | CN101260048A Method for preparing rasagiline |
| 09/10/2008 | CN101259283A Anti-depression noncovalent complex with high dissolvability and preparation thereof |
| 09/10/2008 | CN101259257A Preparation of Chinese medicine for treating facial neuritis |
| 09/10/2008 | CN101259234A Medicinal composition for treating senile dementia and preparation thereof |
| 09/10/2008 | CN101259219A Medicaments for treating intractable headache and making method |
| 09/10/2008 | CN101259199A Compound giving up smoking composition and substituted tobacco prepared from the same |
| 09/10/2008 | CN101259193A Medicinal composition for treating angioneurotic headache and preparation thereof |
| 09/10/2008 | CN101259181A Preparation of qinkailing freeze-dried injection |
| 09/10/2008 | CN101259174A Chinese medicine foot soaking agent for regulating blood pressure and improving sleeping quality |
| 09/10/2008 | CN101259154A Effective component of ligusticum chuanxiong, saposhnikovia divaricata, dahurian angelica root for treating vascular diseases and its components compatibility formula |
| 09/10/2008 | CN101259151A Preparation technique for passionflower total flavones and total saponins without alkaloid and cyanogenic glycoside |
| 09/10/2008 | CN101259134A New pharmaceutical use of echinacoside |
| 09/10/2008 | CN101259120A Methods of inducing terminal differentiation |
| 09/10/2008 | CN101258889A Dormancy-aiding tea beverage |
| 09/10/2008 | CN100417648C 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 09/10/2008 | CN100417406C Dripping pills preparation for treating angioneurotic headache |
| 09/10/2008 | CN100417400C Medicine for treating depression |
| 09/10/2008 | CN100417395C Biological preparation capable of improving cardio cerebral function |
| 09/10/2008 | CN100417386C Compound medicament composed of gastrodine and ligustrazine |
| 09/09/2008 | US7423179 Used to treat mood disorders (e.g., depression), anxiety disorders (e.g., obsessive compulsive disorder), behavioral disorders, eating disorders, substance abuse disorders and sexual disorders and for prevention of migraines |
| 09/09/2008 | US7423177 Carboxamide derivatives as therapeutic agents |
| 09/09/2008 | US7423175 Vanilloid receptor (VR1) antagonists; side effects reduction, oral availability; To treat urinary incontinence, urge urinary incontinence, overactive bladder, pain, and/or inflammatory diseases such as asthma and COPD; N-[2-(2-Fluorophenoxy)ethyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)-urea |
| 09/09/2008 | US7423154 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
| 09/09/2008 | US7423067 Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists |
| 09/09/2008 | US7423059 Pharmaceutically active compounds and methods of use |
| 09/09/2008 | US7423055 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 09/09/2008 | US7423052 Piperidine compounds for use as orexin receptor antagoinst |
| 09/09/2008 | US7423050 2,4,6-trifluoro-N-[6-[(1-methyl-4-piperidinyl)carbonyl]-2-pyridinyl]-benzamide (hemisuccinate/hydrochloride salt); migraine; inhibit peptide extravasation, while avoiding significant vasoconstrictive activity; improved solubility |
| 09/09/2008 | US7423049 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 09/09/2008 | US7423047 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 09/09/2008 | US7423034 Benzothiazine and benzothiadiazine compounds |
| 09/09/2008 | US7423020 Therapy for behavior disorders; quantitative analysis; measuring binding |
| 09/09/2008 | US7423014 Insulin conjugates for treating diabetes mellitus |
| 09/09/2008 | US7423011 Treating autoimmune diseases such as multiple sclerosis with CXCR4 antagonist such as peptides having of stromal cell derived factor one (SDF-1) sequences |
| 09/09/2008 | US7422906 Apoptosis-inducing gene and utilization of the same |
| 09/09/2008 | US7422877 Activatable recombinant neurotoxins |
| 09/09/2008 | US7422846 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 09/09/2008 | CA2474904C Once-a-day oxycodone formulations |
| 09/09/2008 | CA2409069C Hydrogel composition for transdermal drug delivery |
| 09/09/2008 | CA2366205C Biphenyl derivatives |
| 09/09/2008 | CA2359357C Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances |
| 09/09/2008 | CA2346868C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 09/09/2008 | CA2323086C Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/09/2008 | CA2252163C D-proline derivatives |
| 09/09/2008 | CA2211646C Substituted phenyl compounds as endothelin antagonists |
| 09/04/2008 | WO2008106633A1 Methods of using benzodioxine compounds in treating sodium channel-mediated diseases or conditions |
| 09/04/2008 | WO2008105526A1 Macrocyclic compound |
| 09/04/2008 | WO2008105507A1 Therapeutic agent for spinal cord injury |
| 09/04/2008 | WO2008105498A1 Pharmaceutical composition for ameliorating inflammation induced by il-17 |
| 09/04/2008 | WO2008105497A1 Benzimidazole compound and pharmaceutical use thereof |
| 09/04/2008 | WO2008105495A1 Bis(tetrahydrofuran) compound, method for production of the compound, and use of the compound |
| 09/04/2008 | WO2008105445A1 Transdermal pharmaceutical composition |
| 09/04/2008 | WO2008105442A1 Sulfonamide derivative |
| 09/04/2008 | WO2008105392A1 3-amino-2-indolylbutyrolactam derivative, process for production of the same, and pharmaceutical agent comprising the same as active ingredient |
| 09/04/2008 | WO2008105384A1 Citrulline-containing tablet |
| 09/04/2008 | WO2008105383A1 Pyrazole derivative and use thereof for medical purposes |
| 09/04/2008 | WO2008105368A1 Amino acid composition |
| 09/04/2008 | WO2008105325A1 Citrulline-containing beverage |
| 09/04/2008 | WO2008105088A1 Agent for treating spinal cord injury |
| 09/04/2008 | WO2008104737A1 Improved medicinal compositions comprising buprenorphine and naloxone |